Growth funding Five Lives has secured funding of approximately $5.8 million, with a notable €3.7 million round led by Headline and Speedinvest, signaling investor confidence and a runway to scale the dementia prevention and brain health platforms.

Healthcare audience The company targets adults 50 and older, including those with mild cognitive impairment, creating opportunities to cross-sell to caregivers, clinicians, memory clinics, and senior living providers seeking digital therapeutics and remote brain health monitoring.

Dual product lines Two offerings exist: a prevention app with a large user base and a therapeutic cognitive remediation app, suggesting upsell potential across stages of cognitive health and partnerships with hospitals, payers, and DTx distributors.

Moderate size Smaller teams (11-50 employees) can enable agile pilots and rapid ROI proofs with select healthcare partners, making it conducive to trial collaborations, channel partnerships, and co-development deals.

Tech and credibility Clinically validated assessments and gamified coaching bolster credibility; potential sales angles include integration with health platforms, data interoperability with EHR/PHR systems, and enterprise-grade secure delivery for clinics and aging services.